210 related articles for article (PubMed ID: 33138778)
21. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.
Wilson J; Yao GL; Raftery J; Bohlius J; Brunskill S; Sandercock J; Bayliss S; Moss P; Stanworth S; Hyde C
Health Technol Assess; 2007 Apr; 11(13):1-202, iii-iv. PubMed ID: 17408534
[TBL] [Abstract][Full Text] [Related]
22. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Aher SM; Ohlsson A
Cochrane Database Syst Rev; 2006 Jul; (3):CD004865. PubMed ID: 16856063
[TBL] [Abstract][Full Text] [Related]
23. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Aher SM; Ohlsson A
Cochrane Database Syst Rev; 2014 Apr; (4):CD004868. PubMed ID: 24760628
[TBL] [Abstract][Full Text] [Related]
24. Erythropoietin treatment in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
Gao D; Ning N; Niu X; Dang Y; Dong X; Wei J; Zhu C
Am Heart J; 2012 Nov; 164(5):715-727.e1. PubMed ID: 23137502
[TBL] [Abstract][Full Text] [Related]
25. Cause and Timing of Death and Subgroup Differential Effects of Erythropoietin in the EPO-TBI Study.
Skrifvars MB; French C; Bailey M; Presneill J; Nichol A; Little L; Durantea J; Huet O; Haddad S; Arabi Y; McArthur C; Cooper DJ; Bellomo R
J Neurotrauma; 2018 Jan; 35(2):333-340. PubMed ID: 29020866
[TBL] [Abstract][Full Text] [Related]
26. Comparative safety of multiple doses of erythropoietin for the treatment of traumatic brain injury: A systematic review and network meta-analysis.
Zheng Q; Duan D; Xu J; Wang X; Ge Y; Xiong L; Yang J; Wulayin S; Luo X
Front Neurol; 2022; 13():998320. PubMed ID: 36582613
[TBL] [Abstract][Full Text] [Related]
27. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Vale L; Wallace S; MacLeod A
Cochrane Database Syst Rev; 2002; (4):CD003895. PubMed ID: 12519614
[TBL] [Abstract][Full Text] [Related]
28. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Aher SM; Ohlsson A
Cochrane Database Syst Rev; 2012 Sep; (9):CD004868. PubMed ID: 22972077
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and Safety of Erythropoietin to Prevent Acute Kidney Injury in Patients With Critical Illness or Perioperative Care: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Zhao C; Lin Z; Luo Q; Xia X; Yu X; Huang F
J Cardiovasc Pharmacol; 2015 Jun; 65(6):593-600. PubMed ID: 26065644
[TBL] [Abstract][Full Text] [Related]
30. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Aher SM; Ohlsson A
Cochrane Database Syst Rev; 2012 Oct; 10():CD004865. PubMed ID: 23076909
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietin in perinatal hypoxic-ischemic encephalopathy: a systematic review and meta-analysis.
Razak A; Hussain A
J Perinat Med; 2019 May; 47(4):478-489. PubMed ID: 30789826
[TBL] [Abstract][Full Text] [Related]
32. Levetiracetam Versus Phenytoin for Seizure Prophylaxis Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis.
Yang Y; Zheng F; Xu X; Wang X
CNS Drugs; 2016 Aug; 30(8):677-88. PubMed ID: 27395404
[TBL] [Abstract][Full Text] [Related]
33. Time to reconsider extended erythropoietin treatment for infantile traumatic brain injury?
Jantzie L; El Demerdash N; Newville JC; Robinson S
Exp Neurol; 2019 Aug; 318():205-215. PubMed ID: 31082389
[TBL] [Abstract][Full Text] [Related]
34. EPO treatment does not alter acute serum profiles of GFAP and S100B after TBI: A brief report on the Australian EPO-TBI clinical trial.
Hellewell SC; Conquest A; Little L; Vallance S; Board J; Bellomo R; Cooper DJ; Morganti-Kossmann MC
J Clin Neurosci; 2020 Jun; 76():5-8. PubMed ID: 32331937
[TBL] [Abstract][Full Text] [Related]
35. Erythropoietin regulates immune/inflammatory reaction and improves neurological function outcomes in traumatic brain injury.
Zhou ZW; Li F; Zheng ZT; Li YD; Chen TH; Gao WW; Chen JL; Zhang JN
Brain Behav; 2017 Nov; 7(11):e00827. PubMed ID: 29201540
[TBL] [Abstract][Full Text] [Related]
36. Erythropoietin in traumatic brain injury associated acute kidney injury: A randomized controlled trial.
Skrifvars MB; Moore E; Mårtensson J; Bailey M; French C; Presneill J; Nichol A; Little L; Duranteau J; Huet O; Haddad S; Arabi Y; McArthur C; Cooper DJ; Bellomo R;
Acta Anaesthesiol Scand; 2019 Feb; 63(2):200-207. PubMed ID: 30132785
[TBL] [Abstract][Full Text] [Related]
37. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Ohlsson A; Aher SM
Cochrane Database Syst Rev; 2014 Apr; (4):CD004863. PubMed ID: 24771408
[TBL] [Abstract][Full Text] [Related]
38. Erythropoietin to Reduce Mortality in Traumatic Brain Injury: A Post-hoc Dose-effect Analysis.
Gantner DC; Bailey M; Presneill J; French CJ; Nichol A; Little L; Bellomo R; ;
Ann Surg; 2018 Mar; 267(3):585-589. PubMed ID: 28151802
[TBL] [Abstract][Full Text] [Related]
39. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A
Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180
[TBL] [Abstract][Full Text] [Related]
40. Effect of progesterone administration on the prognosis of patients with severe traumatic brain injury: a meta-analysis of randomized clinical trials.
Pan ZY; Zhao YH; Huang WH; Xiao ZZ; Li ZQ
Drug Des Devel Ther; 2019; 13():265-273. PubMed ID: 30666088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
